T&R Biofab Co., Ltd. (KOSDAQ:246710)
2,020.00
-25.00 (-1.22%)
Jun 10, 2026, 3:30 PM KST
T&R Biofab Market Cap
T&R Biofab has a market cap or net worth of 96.28 billion as of June 10, 2026. Its market cap has decreased by -4.93% in one year.
Market Cap
96.28B
Enterprise Value
119.01B
Revenue
29.73B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,020.00
Market Cap Chart
Since November 28, 2018, T&R Biofab's market cap has decreased from 101.48B to 96.28B, a decrease of -5.12%. That is a compound annual growth rate of -0.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 96.28B | -46.29% |
| Dec 30, 2025 | 179.28B | 91.93% |
| Dec 30, 2024 | 93.41B | -51.40% |
| Dec 28, 2023 | 192.21B | -20.80% |
| Dec 29, 2022 | 242.68B | -53.25% |
| Dec 30, 2021 | 519.07B | 265.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio Plus | 299.70B |
| DRTECH | 110.86B |
| Osang Healthcare Co.,Ltd | 91.47B |
| P&S Robotics | 79.52B |
| Ray Co., Ltd. | 77.50B |
| Sugentech | 76.37B |
| LabGenomics | 64.14B |
| Gencurix | 58.80B |